{"id":2641,"date":"2014-03-28T12:35:57","date_gmt":"2014-03-28T11:35:57","guid":{"rendered":"https:\/\/info.beaz.bizkaia.eus\/?p=2641"},"modified":"2023-10-26T08:00:44","modified_gmt":"2023-10-26T06:00:44","slug":"la-caixak-eta-cdtik-kapital-arriskuaren-funts-bat-atera-dute-enpresa-bioteknologikoak-bultatzeko","status":"publish","type":"post","link":"https:\/\/info.beaz.bizkaia.eus\/eu\/albistea\/la-caixak-eta-cdtik-kapital-arriskuaren-funts-bat-atera-dute-enpresa-bioteknologikoak-bultatzeko\/","title":{"rendered":"La Caixak eta CDTIk kapital arriskuaren funts bat atera dute enpresa bioteknologikoak bultatzeko"},"content":{"rendered":"<p><a href=\"http:\/\/www.caixacapitalrisc.es\/es\/category\/ciencias-de-la-vida\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-2542 alignleft\" alt=\"Caixa Innvierte BioMed\" src=\"https:\/\/info.beaz.bizkaia.eus\/wp-content\/uploads\/2014\/03\/Caixa-Innvierte-BioMed.png\" width=\"180\" height=\"120\" \/>Caixa Capital Risc<\/a>ek, CDTIrekin lankidetzan, inbertsio-bitarteko berria (Caixa InnvierteBioMed II) atera du, bizi-zientzien sektoreko enpresetarako, horiek hazkuntza-fasean badaude.\u00a0<!--more--><\/p>\n<p>Caixa InnvierteBioMed IIk 35 milioi euroko inbertsio-bolumena izango du. Batez beste eragiketako 2,5 milioi euro inbertitzea aurrez ikusia dago. Ildo horri eutsiz, konpainia bakoitzean gutxienez 500.000 euroko eta gehienez 4,5 milioi euroko kapitala bideratu beharko da.Caixa Innvierte BioMed II tendr\u00e1 un volumen de inversi\u00f3n de 35 millones de euros. Se estima que la inversi\u00f3n media por\u00a0operaci\u00f3n ser\u00e1 de 2,5 millones de euros, destinando\u00a0un capital m\u00ednimo\u00a0de 500.000 euros y\u00a0un m\u00e1ximo de 4,5 millones de euros en cada compa\u00f1\u00eda.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Caixa Capital Riscek, CDTIrekin lankidetzan, inbertsio-bitarteko berria (Caixa InnvierteBioMed II) atera du, bizi-zientzien sektoreko enpresetarako, horiek hazkuntza-fasean badaude.\u00a0<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[61,64],"tags":[],"class_list":["post-2641","post","type-post","status-publish","format-standard","hentry","category-albistea","category-beste-albisteak"],"wpml":{"es":{"post_id":"2541","post_title":"La Caixa y el CDTI lanzan un fondo de capital riesgo para impulsar empresas biotecnol\u00f3gicas","post_excerpt":"Caixa Capital Risc. en colaboraci\u00f3n con el CDTI,\u00a0\u00a0lanza un nuevo veh\u00edculo de inversi\u00f3n -Caixa\u00a0Innvierte BioMed II- dirigido a empresas del sector de las ciencias de la vida que est\u00e1n en [&hellip;]","post_url":"https:\/\/info.beaz.bizkaia.eus\/noticia\/la-caixa-y-el-cdti-lanzan-un-fondo-de-capital-riesgo-para-impulsar-las-empresas-biotecnologicas\/"}},"_links":{"self":[{"href":"https:\/\/info.beaz.bizkaia.eus\/eu\/wp-json\/wp\/v2\/posts\/2641","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/info.beaz.bizkaia.eus\/eu\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/info.beaz.bizkaia.eus\/eu\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/info.beaz.bizkaia.eus\/eu\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/info.beaz.bizkaia.eus\/eu\/wp-json\/wp\/v2\/comments?post=2641"}],"version-history":[{"count":0,"href":"https:\/\/info.beaz.bizkaia.eus\/eu\/wp-json\/wp\/v2\/posts\/2641\/revisions"}],"wp:attachment":[{"href":"https:\/\/info.beaz.bizkaia.eus\/eu\/wp-json\/wp\/v2\/media?parent=2641"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/info.beaz.bizkaia.eus\/eu\/wp-json\/wp\/v2\/categories?post=2641"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/info.beaz.bizkaia.eus\/eu\/wp-json\/wp\/v2\/tags?post=2641"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}